Last reviewed · How we verify
NCT05932706
Intervention Effect of High Definition Transcranial Alternating Current Stimulation (HD-tACS) on Depressive Disorder
NA trial testing High definition transcranial alternating current stimulation in Transcranial Alternating Current Stimulation in 60 participants. Completed in 20 February 2025.
20 February 2025
Quick facts
| Lead sponsor | Anhui Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 September 2022 |
| Primary completion | 20 February 2025 |
| Estimated completion | 20 February 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- High definition transcranial alternating current stimulation
- sham high definition transcranial alternating current stimulation
Conditions studied
- Transcranial Alternating Current Stimulation — all drugs for Transcranial Alternating Current Stimulation →
- Depressive Disorder — all drugs for Depressive Disorder →
Sponsor
Anhui Medical University
Who can join
Adults 18 to 65, any sex, with Transcranial Alternating Current Stimulation or Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the intervention effect of high definition transcranial alternating current stimulation (HD-tACS) on suicidal ideation in patients with depressive disorder and its underlying neural mechanism by magnetic resonance imaging (MRI) and electroencephalography (EEG).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05932706
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High definition transcranial alternating current stimulation
Trials testing the same drug.
- NCT05502822 — High Definition Transcranial Alternating Current Stimulation (HD-tACS) for Post-stroke Aphasia · NA · unknown
Other recruiting trials for Transcranial Alternating Current Stimulation
Currently open trials in the same condition.
- NCT07087873 — Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiop · NA · recruiting
- NCT06874374 — Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder · NA · active not recruiting
- NCT06888726 — Efficacy of Hi-tACS for Schizophrenia Negative Symptoms · NA · recruiting
- NCT06565143 — Effect of Transcranial Alternating Current Stimulation(tACS) for Early Alzheimer's Disease · NA · recruiting
Other Anhui Medical University trials
Trials by the same sponsor.
- NCT07403591 — Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder · NA · not yet recruiting
- NCT07112612 — Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer · not yet recruiting
- NCT07112599 — Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis · recruiting
- NCT07176468 — Personalized iTBS in Real-World Clinical Settings for Schizophrenia · NA · recruiting
- NCT07486804 — Effects of taVNS Combined With tACS on Adolescents With Non-Suicidal Self-Injury · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05932706 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anhui Medical University
- Last refreshed: 21 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05932706.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing